$Biofrontera(BFRI.US)$Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG 3 MINUTES AGO, 8:10 AM EST VIA ACCESSWIRE BFRI SHARE Ameluz ® transfer price to Biofrontera AG reduced significantly Control of all US clinical trials of Ameluz transfers to Biofrontera Inc. on June 1
Biofrontera股票讨论区
接入线·
根据纳斯达克规则,公司完成了800万澳元的融资,第二笔融资与里程碑挂钩,总收益为1,600万美元,按市价计算
融资和最近的供应协议重组使Biofrontera Inc得以开展研发活动并支持进一步的商业增长
暂无评论